Installieren Freie Wechselkurse in Ihre Webseite!
- Association Between Use of Non–Vitamin K Oral . . .
Key Points Question What is the risk of major bleeding among patients with nonvalvular atrial fibrillation treated with non–vitamin K oral anticoagulants (NOACs) in combination with medications that share metabolic pathways? Findings Among 91 330 NOAC users in Taiwan, the risk of major bleeding was significantly increased with concurrent use of amiodarone, fluconazole, rifampin, or
- Frequent use of aspirin can lead to increased bleeding . . .
A new study has found that taking aspirin on a regular basis to prevent heart attacks and strokes, can lead to an increase risk of almost 50 percent in major bleeding episodes
- Long-term daily aspirin use linked to higher than expected . . .
In people aged 75 or over, long-term daily aspirin use is linked to a higher than expected risk of disabling or fatal bleeding, according to a new study in The Lancet While short-term aspirin use
- Final Recommendation Statement: Aspirin Use to Prevent . . .
Population Recommendation Grade (What's This?) Adults aged 50 to 59 years with a ≥10% 10-year CVD risk: The USPSTF recommends initiating low-dose aspirin use for the primary prevention of cardiovascular disease (CVD) and colorectal cancer (CRC) in adults aged 50 to 59 years who have a 10% or greater 10-year CVD risk, are not at increased risk for bleeding, have a life expectancy of at least
- Use of aspirin to reduce risk of initial vascular events . . .
The event rate was much lower than expected, which is probably reflective of contemporary risk management strategies, making the study more representative of a low-risk population The role of aspirin in primary prevention among patients at moderate risk could therefore not be addressed Nonetheless, the findings with respect to aspirin's effects are consistent with those observed in the
- Taking a daily aspirin causes the risk of major bleeding . . .
TAKING a daily aspirin raises the risk of deadly bleeds by nearly 50 per cent, a study reveals Millions of Brits regularly use the painkiller to slash their chances of heart attacks and strokes
- Aspirin in Patients Undergoing Noncardiac Surgery | NEJM
Background There is substantial variability in the perioperative administration of aspirin in patients undergoing noncardiac surgery, both among patients who are already on an aspirin regimen and
- Aspirin Use for the Primary Prevention of CVD and CRC . . .
The USPSTF recommends initiating low-dose aspirin use for the primary prevention of cardiovascular disease (CVD) and colorectal cancer (CRC) in adults aged 50 to 59 years who have a 10% or greater 10-year CVD risk, are not at increased risk for bleeding, have a life expectancy of at least 10 years, and are willing to take low-dose aspirin daily for at least 10 years